![Foto de ALFREDO](/img/nophoto.png)
ALFREDO
PAREDES LARIO
Chercheur jusqu' 2022
Publications (35) Publications de ALFREDO PAREDES LARIO
2024
-
Power of Light: Raman Spectroscopy and Machine Learning for the Detection of Lung Cancer
ACS Omega, Vol. 9, Núm. 12, pp. 14084-14091
-
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789
2022
-
Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program
Oncotarget, Vol. 13, Núm. 1, pp. 812-827
2021
-
Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: A 3-month follow-up analysis
BMJ Supportive and Palliative Care, Vol. 11, Núm. 1, pp. 25-31
-
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Cancer Medicine, Vol. 10, Núm. 17, pp. 5878-5888
-
One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study
BMJ Supportive and Palliative Care
-
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
Lung Cancer, Vol. 153, pp. 25-34
2020
-
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort
Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148
-
Changes in lung cancer survival by TNM stage in the Basque country from 2003 to 2014 according to period of diagnosis
Cancer Epidemiology, Vol. 65
2018
-
Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain
BMC Cancer, Vol. 18, Núm. 1
-
Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1261-1267
-
LungBEAM: A prospective multicenter trial to monitor EGFR mutations using BEAMing technology in stage IV NSCLC patients
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii38
2016
-
147P: Level of concordance between EGFR mutation status obtained from tissue/cytology and blood (plasma) for advanced non-small-cell lung cancer in Spain: ASSESS study
Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S122
2013
-
Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS
Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121
2007
-
Expresión de proteínas relacionadas con resistencia a múltiples drogas (MDR-proteínas) y su implicación pronóstica en la supervivencia en el cáncer de pulmón
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 104, Núm. 2, pp. 51-63
-
Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial
Lung Cancer, Vol. 58, Núm. 2, pp. 238-245
2006
-
Expresión de Proteínas Relacionadas con Resistencia a Múltiples Drogas (MDR-Proteínas) en tumores sólidos
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 103, Núm. 4, pp. 163-175
-
Expresión de proteinas relacionadas con resistencia a múltiples drogas (MDR-proteinas) y resistencia a la quimioterapia en el cáncer de pulmón
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 103, Núm. 3, pp. 105-117
-
Expresión de proteínas relacionadas con resistencia a múltiples drogas (MDR-Proteínas) y resistencia a la quimioterapia en el cáncer de pulmón
Oncología, Vol. 29, Núm. 6, pp. 21-29
-
Expresión de proteínas relacionadas con resistencia a múltiples drogas (MDR-proteínas) y resistencia a la quimioterapia en el cáncer de pulmón
Oncologia, Vol. 29, Núm. 6, pp. 245-253